Though a large proportion of patients receiving oral immunotherapy (OIT) for food allergy report gastrointestinal (GI) symptoms, a knowledge gap remains for the best approach to determine the ...

Food allergen oral immunotherapy (OIT) showed a positive effect on health-related quality of life (HRQL) approximately 1 year after the treatment was completed, based on data from a systematic review ...

Low-dose oral immunotherapy (OIT) had a favorable safety profile and resulted in fewer severe reactions in preschoolers with single or multiple food allergies. Between May 2019 and October 2022, ...

The SBIR Grant will support developing a digital platform for OIT regimens that builds a bridge between patients, allergists, and pharma. Regarding the award, Alerje’s CEO and Founder Javier Evelyn ...

Thirty-six percent of patients treated with omalizumab were able to tolerate 2000mg of peanut protein and 2 other food allergens without experiencing an allergic reaction compared with 19% of ...

Please provide your email address to receive an email when new articles are posted on . The days of passive reactive management have passed; it’s time to be proactive. Patients may be able to add ...

Research powered by the FARE Clinical Network and the FARE Patient Registry advances scientific understanding and informs ...

SAN DIEGO, Feb. 27, 2025 /PRNewswire/ -- Latitude Food Allergy Care, the leading network of food allergy clinics in the United States, today announced findings of a study led by Weill Cornell Medicine ...

Robert Wood, MD, of Johns Hopkins University Medical School, discusses remibrutinib, omalizumab, and OIT for treating food allergy at AAAAI 2026. Clinical Advisor, a trusted source of medical news and ...

Metabolites—small molecules within cells, biofluids, tissues or organisms—play an integral role in various diseases, and studying the many metabolites (metabolomics) can teach us how the body works in ...